What women's health research still doesn't know
There is no reliable diagnostic test for perimenopause, no confirmed cause for endometriosis, no clear mechanism for PMDD, and very limited safety data on medication use in pregnancy because pregnant women are routinely excluded from trials. These are not obscure edge cases. They are central questions in the health of half the population, and they remain open.
Why an article about ignorance is useful
Most health content is written to sound certain. Certainty sells. But if you have ever been told your symptoms do not match any known pattern, it is worth knowing how much genuinely is unknown, because the alternative explanation you are usually offered is that the problem is you.
1. Nobody can reliably diagnose perimenopause
There is no blood test. Hormone levels fluctuate so much day to day that a single measurement tells you almost nothing. Diagnosis is made from age, symptom pattern and cycle changes, which means it depends entirely on a clinician who is listening and who knows the pattern.
This is also why women in their late 30s are so often told they are too young. The diagnosis rests on recognition, and recognition is inconsistent.
2. The cause of endometriosis is unresolved
The condition has been documented for well over a century. Several theories exist, including retrograde menstruation, cellular metaplasia and immune dysfunction, and none fully explains the disease.
Consequences: no cure, no non-invasive diagnostic test in routine use, and treatment that largely manages symptoms rather than addressing cause.
3. PMDD has no confirmed mechanism
Premenstrual dysphoric disorder affects a meaningful minority of women and can be severe. The leading hypothesis is abnormal sensitivity to normal hormonal fluctuation rather than abnormal hormone levels themselves. Why some women have that sensitivity is not established.
4. We know remarkably little about medication in pregnancy
Pregnant women are excluded from most clinical trials for ethical reasons. The result is a paradox: to avoid risk in research, we create risk in practice, because prescribing decisions in pregnancy often rest on thin data.
5. Contraceptive side effects are under-studied
Hormonal contraception is among the most widely used medications in the world. Research on mood effects in particular has been limited and inconsistent, which is why women reporting mood changes on the pill have so often been told there is no known link, when the honest answer is that it has not been studied well enough to say.
6. Menopause research is thin relative to its universality
Every woman who lives long enough goes through menopause. Research funding has not historically reflected that, and the reversals in how hormone therapy has been communicated over the past two decades left both patients and clinicians uncertain, with many women losing access to a treatment whose risk profile is more nuanced than the headlines conveyed.
7. Female pain conditions are disproportionately understudied
Conditions that predominantly affect women, including chronic pelvic pain, fibromyalgia, interstitial cystitis and vulvodynia, have historically received less research attention relative to how many people they affect and how much they disrupt life.
What to do with this
When something does not fit, that is information, not evidence that you are exaggerating
"We don't know" is a legitimate clinical answer. "It's nothing" is not the same thing
Be sceptical of confident wellness claims. If the research community says a mechanism is unresolved, no supplement brand has quietly solved it
Ask what is known versus assumed. Good clinicians answer that question willingly
Our position
We sell herbal tea. We are careful to say traditionally used rather than proven, and to name where evidence is limited, because in a field with this many open questions, overstating is the easy thing and the wrong thing. What we can be precise about is what is in the blend and where it came from, which is on our Traceability page.
This article is educational and not medical advice.
